How will the newly MHRA licenced CGT Catapult manufacturing centre support developers in the UK?
In this newsletter:
- How will the newly MHRA licenced CGT Catapult manufacturing centre support developers in the UK?
- What are the implications of cost-utility analysis and budget impact methodologies? Listen to our heath economics webinar.
- Find out about preclinical development of cell-based medicinal products for European markets